Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Adverum Biotechnologies (ADVM) PT Lowered to $4.50 at Chardan Capital Markets
-
Odyssey Marine Exploration (OMEX) Announces Proposed $5M Registered Direct Offering of Common Shares & Warrants
-
Odyssey Marine Exploration Announces Above Market $5.0 Million Registered Direct Offering of Common Stock and Warrants
-
Wrap Technologies Completes $13.68M Financing; Management and Existing Shareholders Purchase Over 25%
-
ARYA Sciences Acquisition Corp. to Commence Separate Trading of its Class A Ordinary Shares and Warrants on November 2, 2018
-
ChaSerg Technology Acquisition Corp. Announces Closing of Underwriter’s Over-Allotment Option in Connection with its Initial Public Offering
-
ChaSerg Technology Acquisition Corp. Announces Closing of Underwriter’s Over-Allotment Option in Connection with its Initial Public Offering
-
Alberton Acquisition Corp. (ALAC) Prices 10M Units IPO at $10/Unit
-
Alberton Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
PlacementTracker Publishes Q3 2018 Private Placement Market League Tables
-
Chardan Serves as Lead Manager for LogicBio Therapeutics
-
Chardan Serves as Lead Manager for Krystal Biotech
-
UPDATE: Chardan Capital Markets Starts Seres Therapeutics (MCRB) at Buy
-
Krystal Biotech (KRYS) Prices 3M Share Offering at $20/Sh
-
LogicBio Therapeutics Announces Pricing of Initial Public Offering
-
LogicBio Therapeutics Announces Pricing of Initial Public Offering
-
Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock
-
Chardan Remains Positive on DMC Global (BOOM)
-
Edtechx Holdings Acquisition Corp. Announces Closing of Full Over-Allotment Option
-
Edtechx Holdings Acquisition Corp. Announces Closing of Full Over-Allotment Option
-
Krystal Biotech (KRYS) Commences $60M Public Offering of Common Stoc
-
Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) PT Raised to $50 at Chardan Capital Markets
-
ChaSerg Technology Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
-
ChaSerg Technology Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
-
Edtechx Holdings Acquisition Corp. Announces Closing of Initial Public Offering
-
ARYA Sciences Acquisition Corp. Announces Closing of $143,750,000 Initial Public Offering, Including Full Exercise of the Underwriters' Over-Allotment Option
-
Kodiak Sciences Inc. Announces Closing of Initial Public Offering
-
Arbutus Provides Update on HBV Development Programs and Announces Appointment of Dr. Gaston Picchio as Chief Development Officer
-
Arbutus Provides Update on HBV Development Programs and Announces Appointment of Dr. Gaston Picchio as Chief Development Officer
-
GenSight Biologics to Participate in Multiple Upcoming Investor Conferences
-
Solid Biosciences to Present at the Chardan Genetic Medicines Conference
-
EdtechX Holdings Acquisition Corp. (EDTXU) Prices 5.5M Unit IPO at $10/Unit
-
EdtechX Holdings Acquisition Corp. Announces Pricing of Initial Public Offering
-
ARYA Sciences Acquisition Corp. (ARYA) Prices 12.5M Unit IPO at $10/Unit
-
ChaSerg Technology Acquisition Corp. (CTAC) Prices 20M Units IPO at $10/Unit
-
ChaSerg Technology Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
-
ChaSerg Technology Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
-
ARYA Sciences Acquisition Corp. Prices $125 Million Initial Public Offering of Securities
-
Krystal Biotech to Present at Chardan Annual Genetic Medicines Conference
-
AVROBIO, Inc. to Present at Chardan's 2nd Annual Genetic Medicines Conference
-
AVROBIO, Inc. to Present at Chardan's 2nd Annual Genetic Medicines Conference
-
Kodiak Sciences (KOD) IPO Opens Flat
-
Peter Lang Joins Chardan as Managing Director
-
Nightstar Therapeutics to Present at Chardan Genetic Medicines Conference
-
Nightstar Therapeutics to Present at Chardan Genetic Medicines Conference
-
Kodiak Sciences Inc. (KOD) Prices 9M Share IPO at $10/Sh

